Elicio Therapeutics Q3 EPS $(1.27) Up From $(22.67) YoY
Portfolio Pulse from Benzinga Newsdesk
Elicio Therapeutics (NASDAQ:ELTX) reported Q3 losses of $(1.27) per share, a 94.4% increase from $(22.67) per share losses in the same period last year.
November 09, 2023 | 11:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elicio Therapeutics reported a significant reduction in losses per share in Q3 compared to the same period last year.
Elicio Therapeutics reported a significant reduction in losses per share for Q3 compared to the same period last year. This indicates an improvement in the company's financial performance, which could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100